{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T01:21:47Z","timestamp":1782955307457,"version":"3.54.5"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:00:00Z","timestamp":1715644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:00:00Z","timestamp":1715644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s13555-024-01178-0","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T04:12:42Z","timestamp":1715659962000},"page":"1683-1696","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Anti-aging Effects of Tirbanibulin 1% Ointment: A Real-Life Experience"],"prefix":"10.1007","volume":"14","author":[{"given":"Federica","family":"Li Pomi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Peterle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"d\u2019Aloja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Di Tano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Vaccaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3515-8441","authenticated-orcid":false,"given":"Francesco","family":"Borgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,14]]},"reference":[{"key":"1178_CR1","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s40257-022-00674-3","volume":"23","author":"L Del Regno","year":"2022","unstructured":"Del Regno L, Catapano S, Di Stefani A, Cappilli S, Peris K. A review of existing therapies for actinic keratosis: current status and future directions. Am J Clin Dermatol. 2022;23:339\u201352. https:\/\/doi.org\/10.1007\/s40257-022-00674-3.","journal-title":"Am J Clin Dermatol"},{"key":"1178_CR2","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1016\/j.jaad.2021.02.082","volume":"85","author":"DB Eisen","year":"2021","unstructured":"Eisen DB, Asgari MM, Bennett DD, et al. Guidelines of care for the management of actinic keratosis. J Am Acad Dermatol. 2021;85:e209\u201333. https:\/\/doi.org\/10.1016\/j.jaad.2021.02.082.","journal-title":"J Am Acad Dermatol"},{"key":"1178_CR3","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.3390\/ijms24021575","volume":"24","author":"L Di Bartolomeo","year":"2023","unstructured":"Di Bartolomeo L, Vaccaro F, Irrera N, et al. Wnt signaling pathways: from inflammation to non-melanoma skin cancers. Int J Mol Sci. 2023;24:1575. https:\/\/doi.org\/10.3390\/ijms24021575.","journal-title":"Int J Mol Sci"},{"key":"1178_CR4","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/0190-9622(91)70113-G","volume":"24","author":"EA Olsen","year":"1991","unstructured":"Olsen EA, Lisa Abernethy M, Kulp-Shorten C, et al. Double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. J Am Acad Dermatol. 1991;24:738\u201343. https:\/\/doi.org\/10.1016\/0190-9622(91)70113-G.","journal-title":"J Am Acad Dermatol"},{"key":"1178_CR5","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1111\/jdv.13626","volume":"30","author":"L Schmitz","year":"2016","unstructured":"Schmitz L, Kahl P, Majores M, Bierhoff E, Stockfleth E, Dirschka T. Actinic keratosis: correlation between clinical and histological classification systems. J Eur Acad Dermatol Venereol. 2016;30:1303\u20137. https:\/\/doi.org\/10.1111\/jdv.13626.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1178_CR6","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/jdv.12848","volume":"29","author":"MT Fern\u00e1ndez-Figueras","year":"2015","unstructured":"Fern\u00e1ndez-Figueras MT, Carrato C, S\u00e1enz X, et al. Actinic keratosis with atypical basal cells (AKI) is the most common lesion associated with invasive squamous cell carcinoma of the skin. J Eur Acad Dermatol Venereol. 2015;29:991\u20137. https:\/\/doi.org\/10.1111\/jdv.12848.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1178_CR7","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/jdv.12026","volume":"27","author":"CA Morton","year":"2013","unstructured":"Morton CA, Szeimies R-M, Sidoroff A, Braathen LR. European Guidelines for topical photodynamic therapy part 2: emerging indications\u2014field cancerization, photorejuvenation and inflammatory\/infective dermatoses. J Eur Acad Dermatol Venereol. 2013;27:672\u20139. https:\/\/doi.org\/10.1111\/jdv.12026.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1178_CR8","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1056\/NEJMoa2024040","volume":"384","author":"A Blauvelt","year":"2021","unstructured":"Blauvelt A, Kempers S, Lain E, et al. Phase\u00a03 trials of tirbanibulin ointment for actinic keratosis. N Engl J Med. 2021;384:512\u201320. https:\/\/doi.org\/10.1056\/NEJMoa2024040.","journal-title":"N Engl J Med"},{"key":"1178_CR9","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.3390\/jcm11061654","volume":"11","author":"MV Heppt","year":"2022","unstructured":"Heppt MV, Dykukha I, Graziadio S, Salido-Vallejo R, Chapman-Rounds M, Edwards M. Comparative efficacy and safety of tirbanibulin for actinic keratosis of the face and scalp in Europe: a systematic review and network meta-analysis of randomized controlled trials. J Clin Med. 2022;11:1654. https:\/\/doi.org\/10.3390\/jcm11061654.","journal-title":"J Clin Med"},{"key":"1178_CR10","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1002\/cpdd.1024","volume":"10","author":"BA Gilchrest","year":"2021","unstructured":"Gilchrest BA. Tirbanibulin: a new topical therapy for actinic keratoses with a novel mechanism of action and improved ease of use. Clin Pharmacol Drug Dev. 2021;10:1126\u20139. https:\/\/doi.org\/10.1002\/cpdd.1024.","journal-title":"Clin Pharmacol Drug Dev"},{"key":"1178_CR11","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/ajd.14151","volume":"64","author":"M Mansilla-Polo","year":"2023","unstructured":"Mansilla-Polo M, Abril-P\u00e9rez C, Mart\u00edn-Torregrosa D, et al. Effectiveness, safety and satisfaction of 1% tirbanibulin ointment in the treatment of actinic keratoses: a prospective study in real clinical practice. Australas J Dermatol. 2023;64:560\u20134. https:\/\/doi.org\/10.1111\/ajd.14151.","journal-title":"Australas J Dermatol"},{"key":"1178_CR12","doi-asserted-by":"publisher","first-page":"4837","DOI":"10.3390\/jcm12144837","volume":"12","author":"MC Kirchberger","year":"2023","unstructured":"Kirchberger MC, Gfesser M, Erdmann M, Schliep S, Berking C, Heppt MV. Tirbanibulin 1% ointment significantly reduces the actinic keratosis area and severity index in patients with actinic keratosis: results from a real-world study. J Clin Med. 2023;12:4837. https:\/\/doi.org\/10.3390\/jcm12144837.","journal-title":"J Clin Med"},{"key":"1178_CR13","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.3390\/ph16121686","volume":"16","author":"E Campione","year":"2023","unstructured":"Campione E, Rivieccio A, Gaeta Shumak R, et al. Preliminary evidence of efficacy, safety, and treatment satisfaction with tirbanibulin 1% ointment: a clinical perspective on actinic keratoses. Pharmaceuticals. 2023;16:1686. https:\/\/doi.org\/10.3390\/ph16121686.","journal-title":"Pharmaceuticals"},{"key":"1178_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3390\/medicina60020225","volume":"60","author":"F Li Pomi","year":"2024","unstructured":"Li Pomi F, Vaccaro M, Pallio G, Rottura M, Irrera N, Borgia F. Tirbanibulin 1% ointment for actinic keratosis: results from a real-life study. Medicina (B Aires). 2024;60:225. https:\/\/doi.org\/10.3390\/medicina60020225.","journal-title":"Medicina (B Aires)"},{"key":"1178_CR15","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/ijd.17054","volume":"63","author":"C Fidanzi","year":"2024","unstructured":"Fidanzi C, Bevilacqua M, Salvia G, Romanelli M, Janowska A. Tirbanibulin and solar lentigo clearance: an aesthetically pleasing side effect? Int J Dermatol. 2024;63:528\u20139. https:\/\/doi.org\/10.1111\/ijd.17054.","journal-title":"Int J Dermatol"},{"key":"1178_CR16","doi-asserted-by":"publisher","first-page":"7956","DOI":"10.3390\/ijms24097956","volume":"24","author":"V Papa","year":"2023","unstructured":"Papa V, Li Pomi F, Borgia F, Vaccaro M, Pioggia G, Gangemi S. Immunosenescence and skin: a state of art of its etiopathogenetic role and crucial watershed for systemic implications. Int J Mol Sci. 2023;24:7956. https:\/\/doi.org\/10.3390\/ijms24097956.","journal-title":"Int J Mol Sci"},{"key":"1178_CR17","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1177\/0963689717725755","volume":"27","author":"S Zhang","year":"2018","unstructured":"Zhang S, Duan E. Fighting against skin aging. Cell Transplant. 2018;27:729\u201338. https:\/\/doi.org\/10.1177\/0963689717725755.","journal-title":"Cell Transplant"},{"key":"1178_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1468-2494.2007.00415.x","volume":"30","author":"MA Farage","year":"2008","unstructured":"Farage MA, Miller KW, Elsner P, Maibach HI. Intrinsic and extrinsic factors in skin ageing: a review. Int J Cosmet Sci. 2008;30:87\u201395. https:\/\/doi.org\/10.1111\/j.1468-2494.2007.00415.x.","journal-title":"Int J Cosmet Sci"},{"key":"1178_CR19","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.3390\/ijms22083974","volume":"22","author":"TM Ansary","year":"2021","unstructured":"Ansary TM, Hossain MdR, Kamiya K, Komine M, Ohtsuki M. Inflammatory molecules associated with ultraviolet radiation-mediated skin aging. Int J Mol Sci. 2021;22:3974. https:\/\/doi.org\/10.3390\/ijms22083974.","journal-title":"Int J Mol Sci"},{"key":"1178_CR20","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.3390\/genes11121450","volume":"11","author":"W Strza\u0142ka","year":"2020","unstructured":"Strza\u0142ka W, Zg\u0142obicki P, Kowalska E, Ba\u017cant A, Dziga D, Bana\u015b AK. The dark side of UV-induced DNA lesion repair. Genes (Basel). 2020;11:1450. https:\/\/doi.org\/10.3390\/genes11121450.","journal-title":"Genes (Basel)"},{"key":"1178_CR21","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/jid.2011.394","volume":"132","author":"J Krutmann","year":"2012","unstructured":"Krutmann J, Morita A, Chung JH. Sun exposure: what molecular photodermatology tells us about its good and bad sides. J Investig Dermatol. 2012;132:976\u201384. https:\/\/doi.org\/10.1038\/jid.2011.394.","journal-title":"J Investig Dermatol"},{"key":"1178_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00332","author":"SN Mueller","year":"2014","unstructured":"Mueller SN, Zaid A, Carbone FR. Tissue-resident T\u00a0cells: dynamic players in skin immunity. Front Immunol. 2014. https:\/\/doi.org\/10.3389\/fimmu.2014.00332.","journal-title":"Front Immunol"},{"key":"1178_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jaad.2009.06.025","volume":"62","author":"MY Park","year":"2010","unstructured":"Park MY, Sohn S, Lee E-S, Kim YC. Photorejuvenation induced by 5-aminolevulinic acid photodynamic therapy in patients with actinic keratosis: a histologic analysis. J Am Acad Dermatol. 2010;62:85\u201395. https:\/\/doi.org\/10.1016\/j.jaad.2009.06.025.","journal-title":"J Am Acad Dermatol"},{"key":"1178_CR24","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.3390\/ijms20092126","volume":"20","author":"J-W Shin","year":"2019","unstructured":"Shin J-W, Kwon S-H, Choi J-Y, et al. Molecular mechanisms of dermal aging and antiaging approaches. Int J Mol Sci. 2019;20:2126. https:\/\/doi.org\/10.3390\/ijms20092126.","journal-title":"Int J Mol Sci"},{"key":"1178_CR25","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0002-9440(10)63337-8","volume":"165","author":"T Quan","year":"2004","unstructured":"Quan T, He T, Kang S, Voorhees JJ, Fisher GJ. Solar ultraviolet irradiation reduces collagen in photoaged human skin by blocking transforming growth factor-\u03b2 type\u00a0II receptor\/Smad signaling. Am J Pathol. 2004;165:741\u201351. https:\/\/doi.org\/10.1016\/S0002-9440(10)63337-8.","journal-title":"Am J Pathol"},{"key":"1178_CR26","first-page":"1218","volume":"15","author":"MA Dohil","year":"2016","unstructured":"Dohil MA. Efficacy, safety, and tolerability of 4% 5-fluorouracil cream in a novel patented aqueous cream containing peanut oil once daily compared with 5% 5-fluorouracil cream twice daily: meeting the challenge in the treatment of actinic keratosis. J Drugs Dermatol. 2016;15:1218\u201324.","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"1178_CR27","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1001\/archdermatol.2009.97","volume":"145","author":"DL Sachs","year":"2009","unstructured":"Sachs DL, Kang S, Hammerberg C, Helfrich Y, Karimipour D, Orringer J, Johnson T, Hamilton TA, Fisher G, Voorhees JJ. Topical fluorouracil for actinic keratoses and photoaging: a clinical and molecular analysis. Arch Dermatol. 2009;145(6):659\u201366. https:\/\/doi.org\/10.1001\/archdermatol.2009.97.","journal-title":"Arch Dermatol."},{"key":"1178_CR28","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/dsu.0000000000000024","volume":"40","author":"COZ Guimar\u00e3es","year":"2014","unstructured":"Guimar\u00e3es COZ, Miot HA, Bagatin E. Five percent 5-fluorouracil in a cream or for superficial peels in the treatment of advanced photoaging of the forearms: a randomized comparative study. Dermatol Surg. 2014;40:610\u20137. https:\/\/doi.org\/10.1111\/dsu.0000000000000024.","journal-title":"Dermatol Surg"},{"key":"1178_CR29","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1001\/jamadermatol.2017.2578","volume":"153","author":"K Korgavkar","year":"2017","unstructured":"Korgavkar K, Lee KC, Weinstock MA. Effect of topical fluorouracil cream on photodamage. JAMA Dermatol. 2017;153:1142. https:\/\/doi.org\/10.1001\/jamadermatol.2017.2578.","journal-title":"JAMA Dermatol"},{"key":"1178_CR30","doi-asserted-by":"publisher","first-page":"756","DOI":"10.36849\/JDD.2020.5123","volume":"19","author":"J Hansen","year":"2020","unstructured":"Hansen J, Larsson T, Dunkelly-Allen N, Veverka K, Feldman S. Real-world effectiveness and safety of field- and lesion-directed treatments for actinic keratosis. J Drugs Dermatol. 2020;19:756\u201362. https:\/\/doi.org\/10.36849\/JDD.2020.5123.","journal-title":"J Drugs Dermatol"},{"key":"1178_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/cosmetics11010003","volume":"11","author":"N Sciamarrelli","year":"2023","unstructured":"Sciamarrelli N, Rosset F, Boskovic S, et al. Simultaneous skin rejuvenation in patients undergoing medical treatment for actinic keratosis and non-melanoma skin cancer: a case series analysis. Cosmetics. 2023;11:3. https:\/\/doi.org\/10.3390\/cosmetics11010003.","journal-title":"Cosmetics"},{"key":"1178_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1046\/j.1440-0960.2002.00635.x","volume":"44","author":"K Gebauer","year":"2003","unstructured":"Gebauer K, Brown P, Varigos G. Topical diclofenac in hyaluronan gel for the treatment of solar keratoses. Australas J Dermatol. 2003;44:40\u20133. https:\/\/doi.org\/10.1046\/j.1440-0960.2002.00635.x.","journal-title":"Australas J Dermatol"},{"key":"1178_CR33","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1046\/j.1365-4362.2001.01324.x","volume":"40","author":"JE Wolf","year":"2001","unstructured":"Wolf JE, Taylor JR, Tschen E, Kang S. Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses. Int J Dermatol. 2001;40:709\u201313. https:\/\/doi.org\/10.1046\/j.1365-4362.2001.01324.x.","journal-title":"Int J Dermatol"},{"key":"1178_CR34","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14370","author":"AA Afify","year":"2020","unstructured":"Afify AA, Hana MR. Comparative evaluation of topical diclofenac sodium versus topical ibuprofen in the treatment of seborrheic keratosis. Dermatol Ther. 2020. https:\/\/doi.org\/10.1111\/dth.14370.","journal-title":"Dermatol Ther"},{"key":"1178_CR35","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4103\/2229-5178.182363","volume":"7","author":"H Aktas","year":"2016","unstructured":"Aktas H, Ergin C, Keseroglu H. Diclofenac Gel may be a new treatment option for seborrheic keratosis. Indian Dermatol Online J. 2016;7:211. https:\/\/doi.org\/10.4103\/2229-5178.182363.","journal-title":"Indian Dermatol Online J"},{"key":"1178_CR36","first-page":"166","volume":"13","author":"N Swanson","year":"2014","unstructured":"Swanson N, Smith CC, Kaur M, Goldenberg G. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: two phase\u00a03, multicenter, randomized, double-blindm placebo-controlled studies. J Drugs Dermatol. 2014;13:166\u20139.","journal-title":"J Drugs Dermatol"},{"key":"1178_CR37","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jaad.2006.10.034","volume":"56","author":"S Metcalf","year":"2007","unstructured":"Metcalf S, Crowson AN, Naylor M, Haque R, Cornelison R. Imiquimod as an antiaging agent. J Am Acad Dermatol. 2007;56:422\u20135. https:\/\/doi.org\/10.1016\/j.jaad.2006.10.034.","journal-title":"J Am Acad Dermatol"},{"key":"1178_CR38","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1111\/jocd.12939","volume":"18","author":"S Altalhab","year":"2019","unstructured":"Altalhab S. The effectiveness of imiquimod 5% cream as an anti-wrinkle treatment: a pilot study. J Cosmet Dermatol. 2019;18:1729\u201332. https:\/\/doi.org\/10.1111\/jocd.12939.","journal-title":"J Cosmet Dermatol"},{"key":"1178_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2023.103800","volume":"44","author":"F Li Pomi","year":"2023","unstructured":"Li Pomi F, Peterle L, Vaccaro M, Borgia F. daylight photodynamic therapy for cutaneous leishmaniasis in a pediatric setting: a case report and literature review. Photodiagnosis Photodyn Ther. 2023;44: 103800. https:\/\/doi.org\/10.1016\/j.pdpdt.2023.103800.","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"1178_CR40","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15313","author":"L Macca","year":"2022","unstructured":"Macca L, Li Pomi F, Custurone P, Vaccaro M, Borgia F. Photodynamic therapy for pediatric genital warts: a case report. Dermatol Ther. 2022. https:\/\/doi.org\/10.1111\/dth.15313.","journal-title":"Dermatol Ther"},{"key":"1178_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2023.103620","volume":"42","author":"F Li Pomi","year":"2023","unstructured":"Li Pomi F, Macca L, Peterle L, Romeo P, Vaccaro M, Borgia F. Photodynamic therapy for intergluteal warts in a child affected by Rett syndrome. Photodiagnosis Photodyn Ther. 2023;42: 103620. https:\/\/doi.org\/10.1016\/j.pdpdt.2023.103620.","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"1178_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2020.101819","volume":"31","author":"F Borgia","year":"2020","unstructured":"Borgia F, Giuffrida R, Coppola M, et al. Efficacy and safety of conventional versus daylight photodynamic therapy in children affected by multiple facial flat warts. Photodiagnosis Photodyn Ther. 2020;31:101819. https:\/\/doi.org\/10.1016\/j.pdpdt.2020.101819.","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"1178_CR43","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.3390\/ijms25073608","volume":"25","author":"F Li Pomi","year":"2024","unstructured":"Li Pomi F, Motolese A, Paganelli A, Vaccaro M, Motolese A, Borgia F. Shedding light on photodynamic therapy in the treatment of necrobiosis lipoidica: a multicenter real-life experience. Int J Mol Sci. 2024;25:3608. https:\/\/doi.org\/10.3390\/ijms25073608.","journal-title":"Int J Mol Sci"},{"key":"1178_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.pdpdt.2019.02.021","volume":"26","author":"F Borgia","year":"2019","unstructured":"Borgia F, Coppola M, Giuffrida R, Cannav\u00f2 SP. Excellent cosmetic result of daylight photodynamic therapy for facial flat warts in a child. Photodiagnosis Photodyn Ther. 2019;26:27\u20138. https:\/\/doi.org\/10.1016\/j.pdpdt.2019.02.021.","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"1178_CR45","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1365-2133.2011.10613.x","volume":"166","author":"T Dirschka","year":"2012","unstructured":"Dirschka T, Radny P, Dominicus R, et al. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase\u00a0III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo. Br J Dermatol. 2012;166:137\u201346. https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10613.x.","journal-title":"Br J Dermatol"},{"key":"1178_CR46","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/bjd.14498","volume":"175","author":"U Reinhold","year":"2016","unstructured":"Reinhold U, Dirschka T, Ostendorf R, et al. A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA(Ameluz\u00ae) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-Rhodo LED\u00ae lamp. Bri J Dermatol. 2016;175:696\u2013705. https:\/\/doi.org\/10.1111\/bjd.14498.","journal-title":"Bri J Dermatol"},{"key":"1178_CR47","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1365-2133.2010.09873.x","volume":"163","author":"R-M Szeimies","year":"2010","unstructured":"Szeimies R-M, Radny P, Sebastian M, et al. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase\u00a0III study. Br J Dermatol. 2010;163:386\u201394. https:\/\/doi.org\/10.1111\/j.1365-2133.2010.09873.x.","journal-title":"Br J Dermatol"},{"key":"1178_CR48","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1524-4725.2009.01385.x","volume":"36","author":"J Pi\u00f1eiro-Maceira","year":"2010","unstructured":"Pi\u00f1eiro-Maceira J, Olej B, Mandarim-De-Lacerda CA, Luiz RR, Manela-Azulay M. Photorejuvenation with topical methyl aminolevulinate and red light: a randomized, prospective, clinical, histopathologic, and morphometric study. Dermatol Surg. 2010;36:39\u201348. https:\/\/doi.org\/10.1111\/j.1524-4725.2009.01385.x.","journal-title":"Dermatol Surg"},{"key":"1178_CR49","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1038\/jid.2013.25","volume":"133","author":"YH Jang","year":"2013","unstructured":"Jang YH, Koo G-B, Kim J-Y, Kim Y-S, Kim YC. Prolonged activation of ERK contributes to the photorejuvenation effect in photodynamic therapy in human dermal fibroblasts. J Investig Dermatol. 2013;133:2265\u201375. https:\/\/doi.org\/10.1038\/jid.2013.25.","journal-title":"J Investig Dermatol"},{"key":"1178_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/jbio.202200293","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Liu W, Wang Q. Positive effects of low-dose photodynamic therapy with aminolevulinic acid or its methyl ester in skin rejuvenation and wound healing: an update. J Biophotonics. 2023. https:\/\/doi.org\/10.1002\/jbio.202200293.","journal-title":"J Biophotonics"},{"key":"1178_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/jbio.201700357","author":"P Wang","year":"2018","unstructured":"Wang P, Han J, Wei M, et al. Remodeling of dermal collagen in photoaged skin using low-dose 5-aminolevulinic acid photodynamic therapy occurs via the transforming growth factor-\u03b2 pathway. J Biophotonics. 2018. https:\/\/doi.org\/10.1002\/jbio.201700357.","journal-title":"J Biophotonics"},{"key":"1178_CR52","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ad.2021.07.006","volume":"113","author":"Y Gilaberte","year":"2022","unstructured":"Gilaberte Y, Fern\u00e1ndez-Figueras MT. Tirbanibulina: Revisi\u00f3n de Su Mecanismo de Acci\u00f3n Novedoso y de C\u00f3mo Encaja En El Tratamiento de La Queratosis Act\u00ednica. Actas Dermosifiliogr. 2022;113:58\u201366. https:\/\/doi.org\/10.1016\/j.ad.2021.07.006.","journal-title":"Actas Dermosifiliogr"},{"key":"1178_CR53","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.2147\/CCID.S374122","volume":"15","author":"T Schlesinger","year":"2022","unstructured":"Schlesinger T, Stockfleth E, Grada A, Berman B. Tirbanibulin for actinic keratosis: insights into the mechanism of action. Clin Cosmet Investig Dermatol. 2022;15:2495\u2013506. https:\/\/doi.org\/10.2147\/CCID.S374122.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"1178_CR54","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s41669-023-00410-5","volume":"7","author":"A Dymond","year":"2023","unstructured":"Dymond A, Green W, Edwards M, Pont MAL, Gupta G. Economic evaluation of tirbanibulin for the treatment of actinic keratosis in Scotland. Pharmacoecon Open. 2023;7:443\u201354. https:\/\/doi.org\/10.1007\/s41669-023-00410-5.","journal-title":"Pharmacoecon Open"},{"key":"1178_CR55","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-023-00839-8","author":"I Aggarwal","year":"2024","unstructured":"Aggarwal I, Puyana C, Chandan N, Jetter N, Tsoukas M. Field cancerization therapies for the management of actinic keratosis: an updated review. Am J Clin Dermatol. 2024. https:\/\/doi.org\/10.1007\/s40257-023-00839-8.","journal-title":"Am J Clin Dermatol"},{"key":"1178_CR56","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/ced\/llad334","volume":"49","author":"F Martora","year":"2024","unstructured":"Martora F, Ascierto PA, Scalvenzi M, et al. Tirbanibulin ointment to manage recurrence of superficial basal cell carcinoma of the face: case report. Clin Exp Dermatol. 2024;49:183\u20135. https:\/\/doi.org\/10.1093\/ced\/llad334.","journal-title":"Clin Exp Dermatol"},{"key":"1178_CR57","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1093\/ced\/llad231","volume":"48","author":"D Blaya Imbern\u00f3n","year":"2023","unstructured":"Blaya Imbern\u00f3n D, Finello M, Labrandero Hoyos C, et al. Successful treatment of bowen disease with 1% tirbanibulin ointment. Clin Exp Dermatol. 2023;48:1184\u20136. https:\/\/doi.org\/10.1093\/ced\/llad231.","journal-title":"Clin Exp Dermatol"},{"key":"1178_CR58","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17957","author":"S Braasch","year":"2022","unstructured":"Braasch S, Gerber PA, Braun SA. Tirbanibulin 1% ointment as a potential novel treatment for anogenital warts. J Eur Acad Dermatol Venereol. 2022. https:\/\/doi.org\/10.1111\/jdv.17957.","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-024-01178-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-024-01178-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-024-01178-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T13:03:54Z","timestamp":1718197434000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-024-01178-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,14]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1178"],"URL":"https:\/\/doi.org\/10.1007\/s13555-024-01178-0","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,14]]},"assertion":[{"value":"10 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Federica Li Pomi, Lucia Peterle, Andrea d\u2019Aloja, Antonio Di Tano, Mario Vaccaro and Francesco Borgia declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki of 1964 and its later amendments. Local ethical committee approval was not required for this study in accordance with national guidelines. Written informed consent was obtained from all patients for their photographs and medical information to be published. Patients\u2019 names, initials, or hospital numbers have not been used.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}